Full Text View
Tabular View
No Study Results Posted
Related Studies
Thrombolysis in Myocardial Ischemia Trial (TIMI III)
This study has been completed.
Study NCT00000472   Information provided by National Heart, Lung, and Blood Institute (NHLBI)
First Received: October 27, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Angina Pectoris
Cardiovascular Diseases
Coronary Disease
Heart Diseases
Myocardial Infarction
Myocardial Ischemia
Additional conditions recognized in this trial
Coronary Artery Disease
Infarction
Ischemia
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Chest Pain
Necrosis
Pain
Pathologic Processes
Signs and Symptoms
Vascular Diseases
Interventions listed in this trial
tissue plasminogen activator
heparin
Additional drug interventions recognized in this trial
Plasminogen
More general drug interventions related to this trial
Cardiovascular Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Hematologic Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Heart, Lung, and Blood Institute (NHLBI)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services